loadpatents
name:-0.024175882339478
name:-0.010126113891602
name:-0.0025269985198975
Li; Lianhai Patent Filings

Li; Lianhai

Patent Applications and Registrations

Patent applications and USPTO patent grants for Li; Lianhai.The latest application filed is for "compounds and methods for treatment of cystic fibrosis".

Company Profile
2.12.23
  • Li; Lianhai - Wuhan CN
  • LI; Lianhai - Pierrefonds CA
  • Li; Lianhai - Quebec CA
  • Li; Lianhai - Montreal CA
  • Li, Lianhai - Kirkland CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Concomitant impedance protection method for half-wavelength transmission line
Grant 10,605,852 - Du , et al.
2020-03-31
Compounds And Methods For Treatment Of Cystic Fibrosis
App 20190210973 - LI; Lianhai ;   et al.
2019-07-11
Concomitant Impedance Protection Method For Half-wavelength Transmission Line
App 20180364292 - Du; Dingxiang ;   et al.
2018-12-20
Methods and compositions for treating bacterial infection
Grant 9,814,719 - Sun , et al. November 14, 2
2017-11-14
Methods And Compositions For Treating Bacterial Infection
App 20170056405 - Sun; Hongmin ;   et al.
2017-03-02
Cyclic molecules as bruton's tyrosine kinase inhibitors
Grant 9,458,162 - Wang , et al. October 4, 2
2016-10-04
Heterocyclic amides compounds which are HDAC6 inhibitors and used as anti-tumoral agents
Grant 9,345,905 - Wang , et al. May 24, 2
2016-05-24
Spirocyclic molecules as protein kinase inhibitors
Grant 9,226,923 - Wang , et al. January 5, 2
2016-01-05
Cyclic Molecules As Bruton's Tyrosine Kinase Inhibitors
App 20150011530 - Wang; Zhaoyin ;   et al.
2015-01-08
Heterocyclic Amides Compounds Which Are Hdac6 Inhibitors And Used As Anti-tumoral Agents
App 20140322229 - Wang; Zhaoyin ;   et al.
2014-10-30
Spirocyclic Molecules As Protein Kinase Inhibitors
App 20140243303 - Wang; Zhaoyin ;   et al.
2014-08-28
Fluoro Substituted Cycloalkanoindoles, Compositions Containing Such Compounds And Methods Of Treatment
App 20120115921 - Berthelette; Carl ;   et al.
2012-05-10
Heterocyclic Derivatives As Inhibitors Of Stearoyl-coenzyme A Delta-9 Desaturase
App 20110301143 - Isabel; Elise ;   et al.
2011-12-08
Substituted 2-naphthoic Acids As Antagonists Of Gpr105 Activity
App 20100298347 - Belley; Michel ;   et al.
2010-11-25
Substituted Fused Pyrimidines As Antagonists Of Gpr105 Activity
App 20100179173 - Guay; Daniel ;   et al.
2010-07-15
Novel Pharmaceutical Compounds
App 20100137371 - Berthelette; Carl ;   et al.
2010-06-03
Fluoro Substituted Cycloalkanoindoles, Compositions Containing Such Compounds And Methods Of Treatment
App 20100081696 - Berthelette; Carl ;   et al.
2010-04-01
Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors
Grant 7,622,501 - Dufresne , et al. November 24, 2
2009-11-24
Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
Grant 7,622,502 - Berthelette , et al. November 24, 2
2009-11-24
Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
Grant 7,618,994 - Berthelette , et al. November 17, 2
2009-11-17
Nitric Oxide Releasing Prodrugs of Diaryl-2-(5H)-Furanones as Cyclooxygenase-2 Inhibitors
App 20080242643 - Dufresne; Claude ;   et al.
2008-10-02
Combination Therapy for Treating Cyclooxygenase-2 Mediated Diseases or Conditions in Patients at Risk of Thrombotic Cardiovascular Events
App 20080242722 - Dufresne; Claude ;   et al.
2008-10-02
Nitric Oxide Releasing Prodrugs of Diaryl-2-(5h)-Furanones as Cyclooxygenase-2 Inhibitors
App 20080227758 - Berthelette; Carl ;   et al.
2008-09-18
Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
App 20080033028 - Berthelette; Carl ;   et al.
2008-02-07
Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
Grant 7,317,036 - Berthelette , et al. January 8, 2
2008-01-08
Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
Grant 7,199,154 - Berthelette , et al. April 3, 2
2007-04-03
Fluoro-methanesulfonyl-substituted cycloalkanoindoles and their use as prostaglandin D2 antagonists
App 20070054951 - Li; Lianhai ;   et al.
2007-03-08
Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors
Grant 7,169,809 - Berthelette , et al. January 30, 2
2007-01-30
Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
App 20060069148 - Berthelette; Carl ;   et al.
2006-03-30
Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
App 20050261245 - Berthelette, Carl ;   et al.
2005-11-24
Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
App 20050124680 - Berthelette, Carl ;   et al.
2005-06-09
Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors
App 20040176331 - Berthelette, Carl ;   et al.
2004-09-09
Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
App 20030158246 - Berthelette, Carl ;   et al.
2003-08-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed